Cargando…
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma
SOX2 is a transcription factor essential for early mammalian development and for the maintenance of stem cells. Recently, SOX2 was identified as a lineage specific oncogene, recurrently amplified and activated in lung and esophageal squamous cell carcinoma (SCC). In this study, we have developed a z...
Autores principales: | Yokota, Etsuko, Yamatsuji, Tomoki, Takaoka, Munenori, Haisa, Minoru, Takigawa, Nagio, Miyake, Noriko, Ikeda, Tomoko, Mori, Tomoaki, Ohno, Serika, Sera, Takashi, Fukazawa, Takuya, Naomoto, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732711/ https://www.ncbi.nlm.nih.gov/pubmed/29262545 http://dx.doi.org/10.18632/oncotarget.21523 |
Ejemplares similares
-
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
por: Fukazawa, Takuya, et al.
Publicado: (2016) -
Clinical application of a lung cancer organoid (tumoroid) culture system
por: Yokota, Etsuko, et al.
Publicado: (2021) -
Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
por: Yoshida, Masakazu, et al.
Publicado: (2018) -
Suppression of Tumor Growth and Downregulation of Platelet‐derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Tumor Cells by Angiogenesis Inhibitor TNP‐470
por: Mori, Jun, et al.
Publicado: (2000) -
False-Positive Cases of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomographic Scans in Metastasis of Esophageal Cancer
por: Yamatsuji, Tomoki, et al.
Publicado: (2017)